Health Condition 1: M339- Dermatopolymyositis, unspecified Health Condition 2: M328- Other forms of systemic lupus erythematosus Health Condition 3: M351- Other overlap syndromes Health Condition 4: M32- Systemic lupus erythematosus (SLE) Health Condition 5: M349- Systemic sclerosis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
nil
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are diagnosed as a case of AICTD (Chronic Cutaneous Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Localised Scleroderma/ Morphea, Systemic sclerosis and Systemic Autoimmune Myopathies) will be included in this study.
Exclusion criteria
Exclusion criteria: 1)Patients presenting of Primary Reynaud’s phenomenon-clinical examination as well as history and laboratory based evidence. 2)Patients of Secondary Reynaud’s Phenomenon caused due to factors such as occupational hazard or polyvinylchloride induced Reynaud’s Phenomenon. 3)Patients diagnosed with all other autoimmune connective tissue disorders that are not included in this study, such as Rheumatoid Arthritis, Antiphospholipid Antibody Syndrome,Mixed connective tissue Disorder, Vasculitis, Polymyalgia Rheumatica, Undiffrentiated Connective Tissue Disorder. 4)Patients who are not fulfilling the respective diagnostic criteria of the Autoimmune Connective Tissue Disorders. 5)Patient who are not willing to sign informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ?To estimate the correlation between Nailfold Capillaroscopy Findings and severity scores in patients with AICTD.Timepoint: IT WILL BE ASSESED ON DAY O being a single visit observational study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)To estimate the correlation between Nailfold Capillaroscopy findings & duration of the disorder. 2)To estimate the correlation between Nailfold Capillaroscopy findings & clinical features of the patient. 2)To estimate the correlation between laboratory parameters & Nailfold Capillaroscopy findings in patients with AICTD. 3)To estimate the difference in nailfold capillaroscopy findings between systemic sclerosis & localized scleroderma (Morphea), similarly among systemic lupus erythematosus (SLE) , subacute cutaneous lupus erythematosus (SCLE) & Chronic Cutaneous Lupus Erythematosus (CCLE). Timepoint: IT WILL BE ASSESED ON DAY 0 being a single visit observational study. | — |
Countries
India
Contacts
Public ContactDr Jigna K Padhiyar
GCS medical college hospital and research centre
Outcome results
None listed